Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease? - Wikidata - wikimedia - TriplyDB

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

http://www.wikidata.org/entity/Q42351258

about

Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study

P2860

Q57212918-1F3B0F65-7047-49E0-ABA9-24B903CC919F

P2860

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

http://www.wikidata.org/entity/Q42351258

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

@en

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

@nl

type

label

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

@en

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

@nl

prefLabel

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

@en

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

@nl

P1433

Q42351258-50E4C1C1-331B-4CFF-8213-B7FE38851C94

P1476

Q42351258-BB85130F-BA12-45CB-8EFF-8EEFD3BC68F9

P2093

Q42351258-2338DB81-9113-447B-A034-414A59E38505

P2860

Q42351258-2040BA5B-3B09-47A9-AB66-62F89AC60D18

Q42351258-210EE18E-0501-4FFA-86C6-1394969C010F

Q42351258-6DC1BC1B-8753-4B60-AC02-CC0DB27DE020

Q42351258-77C5DC74-CBC5-47CE-8748-6D85318CD4D8

Q42351258-7C7A34ED-D583-415D-860C-A7F3EF4DBB58

Q42351258-923E5ED4-226C-40DB-819D-D828FE120BEC

Q42351258-956C87C2-23E5-48B0-BFE2-438910A14B9E

Q42351258-B88C4BFC-BEB3-4A46-8070-E93C14C70F3E

Q42351258-C339E6C7-48D3-4D45-8134-D41D540E01C8

P304

Q42351258-1725C6EE-E356-4860-8180-6DAE2FBB5C93

P31

Q42351258-0E7BCFBC-F2C0-4324-9398-C96D83823956

Q42351258-ec2f0cea-6906-4037-8cd3-7a223b5479c3

P356

Q42351258-F58C0F87-5E85-4CCA-904E-DD3EDD38F73B

P433

Q42351258-53D3734C-B199-4BDC-B269-E26289473865

P478

Q42351258-012CE6BF-71BB-450A-84D8-C5E93EB79541

P577

Q42351258-9C1865B0-F3E7-4970-8F70-C09CC669CFC6

P698

Q42351258-A03F770D-0CAD-4A7E-9007-137BBC90AF29

P921

Q42351258-3F836909-F07F-40A7-8585-1D141D10F251

P932

Q42351258-C920BBA1-336F-4EC2-A2E7-306546F4CE60

P356

IR.2017.15.2.147

P1433

Intestinal research

P1476

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

@en

P2093

Jong Pil Im

http://www.w3.org/2001/XMLSchema#string

P2860

Changing epidemiological trends of inflammatory bowel disease in Asia

Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)

Infliximab maintenance therapy for fistulizing Crohn's disease

Characteristics of Pediatric Inflammatory Bowel Disease in Korea: Comparison with EUROKIDS Data.

Infliximab for the treatment of fistulas in patients with Crohn's disease.

Second Korean guidelines for the management of Crohn's disease.

A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease.

Guidelines for medical treatment of Crohn's perianal fistulas: critical evaluation of therapeutic trials.

Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study.

P304

147-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5217/IR.2017.15.2.147

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28522942

http://www.w3.org/2001/XMLSchema#string

P921

P932

5430004

http://www.w3.org/2001/XMLSchema#string